Researcher profile

Alireza Karimian

Alireza Karimian contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Joint brain tumor segmentation from multi MR sequences through a deep convolutional neural network

Brain tumor segmentation is highly contributive in diagnosing and treatment planning. The manual brain tumor delineation is a time-consuming and tedious task and varies depending on the radiologists skill. Automated brain tumor segmentation is of high importance, and does not depend on either inter or intra-observation. The objective of this study is to automate the delineation of brain tumors from the FLAIR, T1 weighted, T2 weighted, and T1 weighted contrast-enhanced MR sequences through a deep learning approach, with a focus on determining which MR sequence alone or which combination thereof would lead to the highest accuracy therein.

preprint2021arXiv

Quantitative analysis of image quality in low-dose CT imaging for Covid-19 patients

We set out to simulate four reduced dose-levels (60%-dose, 40%-dose, 20%-dose, and 10%-dose) of standard CT imaging using Beer-Lambert's law across 49 patients infected with COVID-19. Then, three denoising filters, namely Gaussian, Bilateral, and Median, were applied to the different low-dose CT images, the quality of which was assessed prior to and after the application of the various filters via calculation of peak signal-to-noise ratio (PSNR), root mean square error (RMSE), structural similarity index measure (SSIM), and relative CT-value bias, separately for the lung tissue and whole-body. The quantitative evaluation indicated that 10%-dose CT images have inferior quality (with RMSE=322.1-+104.0 HU and bias=11.44-+4.49% in the lung) even after the application of the denoising filters. The bilateral filter exhibited superior performance to suppress the noise and recover the underlying signals in low-dose CT images compared to the other denoising techniques. The bilateral filter led to RMSE and bias of 100.21-+16.47 HU, -0.21-+1.20%, respectively in the lung regions for 20%-dose CT images compared to the Gaussian filter with RMSE=103.46-+15.70 HU and bias=1.02-+1.68%, median filter with RMSE=129.60-+18.09 HU and bias=-6.15-+2.24%, and the nonfiltered 20%-dose CT with RMSE=217.37-+64.66 HU and bias=4.30-+1.85%. In conclusion, the 20%-dose CT imaging followed by the bilateral filtering introduced a reasonable compromise between image quality and patient dose reduction.